CMS Hosts Virtual Town Hall on FY2028 New Technology Payment Applications

The Centers for Medicare & Medicaid Services (CMS) is set to conduct a pivotal virtual town hall on December 9-10, 2026, focusing on the new technology add-on payment (NTAP) applications under the hospital inpatient prospective payment system (IPPS) for fiscal year 2028. With a keen emphasis on evaluating whether emerging medical services and technologies demonstrate the necessary substantial clinical improvement for Medicare payment enhancements, this event provides an essential platform for hospitals, physicians, medical device manufacturers, and stakeholders within the healthcare sector.

As healthcare technology continues its rapid evolution, the implications of this town hall cannot be overstated. Participation allows stakeholders to engage directly with CMS decision-makers, fostering a dialogue that can shape future Medicare reimbursement policies. By understanding the criteria that CMS uses to evaluate new technologies, vendors and healthcare providers can position their offerings to align with federal requirements, ensuring eligibility for NTAP. This is particularly critical as healthcare providers increasingly look to integrate innovative solutions that can demonstrate enhanced patient care outcomes.

The outcomes from this engagement are poised to influence how Medicare reimburses for innovative inpatient technologies, making it a must-attend event for those involved in healthcare procurement and vendor participation in the market. Organizations that are developing new inpatient medical technologies are encouraged to leverage the insights and feedback from this forum to enhance their product development strategies, compliance measures, and ultimately, their competitive position in federal healthcare procurement markets.

Stakeholders should take this opportunity not just to voice their perspectives, but to gather valuable insights that can inform their approach to regulatory compliance and improve their overall strategies in navigating the complex landscape of federal health procurement. As the focus on quality improvement in healthcare intensifies, organizations that act on the information gleaned from this town hall are likely to gain a significant competitive edge.

Furthermore, the town hall signifies a broader trend within the federal procurement environment where stakeholder engagement is increasingly valued. This approach not only fosters transparency in the evaluation and approval processes but also encourages innovation by allowing new technologies that meet clinical benchmarks to be recognized and reimbursed appropriately.

In conclusion, the upcoming CMS town hall serves an essential role in shaping the future of healthcare technology reimbursement within the Medicare system. Engaging in this dialogue can be instrumental for procurement professionals and contractors aiming to align their proposals with CMS’s evolving criteria. By actively participating and responding to the agency’s solicitations, stakeholders can help ensure that new medical devices and services qualify for the critical funding needed to support their implementation and success in the marketplace.

• Procurement professionals should align proposals with CMS criteria for eligibility in NTAP reimbursement.
• The town hall serves as a direct channel for stakeholders to influence critical payment policy.
• Organizations developing new inpatient technologies can optimize product positioning based on insights from the event.
• Engagement may improve competitive advantage in federal healthcare procurement landscapes.
• The focus on substantial clinical improvement criteria will be pivotal in the evaluation process.
• Training and preparation for bid submissions should reflect feedback gathered during the town hall.
• Understanding Medicare requirements through direct engagement is crucial for future planning.